MedTrace Logo

Longitudinal Study of Dental Implant Therapy in HIV Positive Patients

NCT01211288 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2020-06-02

Study results available
· View outcomes & findings →

Summary

The purpose is to place implants in HIV positive and HIV negative patients then follow patients over 3 years period of time to evaluate how well dental implants perform in HIV positive patients versus HIV negative patients.

Conditions

  • Dental Implant

Interventions

DEVICE

Astra implants

Root form OsseoSpeed TX Astra Tech Implant System

Sponsors & Collaborators

  • Dentsply Sirona Implants and Consumables

    collaborator INDUSTRY

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Toni T Neumeier, DMD · UAB Dental School

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2019-04-01
Completion
2020-05-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01211288 on ClinicalTrials.gov